Skip to main content

Table 1 Background characteristics for all women recruited into the study (n = 748)

From: The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in rural Uganda: a community-based, placebo-controlled randomised trial

 

Misoprostol

Placebo

Number of women

374

374

Site of recruitment (n, %):

Mbale Regional Referral Hospital

157 (42.0)

153 (40.9)

Busiu (level IV health centre)

119 (31.8)

119 (31.8)

Lwangoli (level III health centre)

56 (15.0)

54 (14.4)

Siira (level III health centre)

42 (11.2)

48 (12.8)

Age (mean, SD)

26.4 (6.2)

26.2 (6.4)

Primary occupation (n, %):

Housewife

277 (74.1)

284 (75.9)

Employed

85 (22.7)

80 (21.4)

Unemployed / student

fc12 ( 3.2)

10 ( 2.7)

Highest level of education completed (n, %):

No education

24 ( 6.4)

27 ( 7.2)

Primary

202 (54.2)

197 (52.7)

Secondary or higher

147 (39.3)

150 (40.1)

Estimated gestational age (mean, SD)

35.3 (1.4)

35.3 (1.5)

Nulliparous (n, %)

81 (21.7)

83 (22.2)

Previous CS deliveries (n, %)

0

365 (97.6)

367 (98.1)

1

7 ( 1.9)

7 ( 1.9)

2

2 ( 0.5)

0

Haemoglobin (mean g/dl, SD, range))

11.2 (1.4) [6.9 – 14.7]

11.2 (1.4) [5.8 – 14.8]

Normal

207 (55.3 %)

214 (57.2 %)

Mild anaemia

136 (36.4 %)

127 (34.0 %)

Moderate anaemia

27 ( 7.2 %)

31 ( 8.3 %)

Severe anaemia*

3 ( 0.8 %)

2 ( 0.5 %)

  1. † : not recorded for 1 participant in misoprostol group
  2. ‡: the number of previous CS was not recorded for one participant and a single CS was assumed
  3. * : anaemia shown by WHO classification: normal (>11 g/dl), mild (9–10.99 g/dl), moderate (7–8.99 g/dl) and severe (<7 g/dl). Data is missing for one participant in the misoprostol arm